Pangea Wellness Inc.
PNGAF · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.20 | 0.25 | -0.01 | -0.00 |
| FCF Yield | -0.41% | -7.96% | -25.35% | -13.05% |
| EV / EBITDA | -11.07 | -25.93 | -2.78 | -3.07 |
| Quality | ||||
| ROIC | -16.20% | -8.77% | 41.97% | 81.24% |
| Gross Margin | 67.31% | 0.00% | 0.00% | 321.76% |
| Cash Conversion Ratio | 0.06 | 1.78 | 0.94 | 0.39 |
| Growth | ||||
| Revenue 3-Year CAGR | -74.49% | -87.10% | -80.63% | -69.89% |
| Free Cash Flow Growth | 93.44% | -199.96% | 0.37% | -1,789.04% |
| Safety | ||||
| Net Debt / EBITDA | 2.81 | 0.54 | 0.96 | 0.28 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.02 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -8,671.73 | 0.00 | 0.00 | 20,553.28 |